FindTrial
Sign In

Pain Reduction In Second Trimester Amniocentesis By Using Ethyl Chloride Spray

Pain Reduction In Second Trimester Amniocentesis By Using Ethyl Chloride Spray

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170404002
Enrollment
Unknown
Registered
2017-04-04
Start date
2015-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduced pain score amniocentesis pain ethylchloride spray vapocoolant spray prenatal diagnosis visual analogue scale

Interventions

Ethyl chloride spray for pain reduction on the site,No spray before procedure
Experimental Drug,No Intervention No treatment
Spray,No spray

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pregnant women who has single viable fetus No contraindication for amniocentesis First time amniocentesis in life No gross anomaly from ultrasound screening All informed consent

Exclusion criteria

Exclusion criteria: Skin allergy to cold temperature History of ethyl chloride spray hypersensitivity Had had analgesic drugs used 4 hours before procedure Needed more than one attempt to success amniocentesis

Design outcomes

Primary

MeasureTime frame
Pain score May to November 2016 Visual analogue scale—

Secondary

MeasureTime frame
Satisfaction of participants May to November 2016 5-point Likert scale—

Countries

Thailand

Contacts

Public ContactKritakarn Telapol

Kritakarn Telapol

koyarh_nub@hotmail.com0863731364

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026